![](/img/cover-not-exists.png)
Tipranavir/Ritonavir (500/200 mg and 500/100 mg) Was Virologically Non-Inferior to Lopinavir/Ritonavir (400/100 mg) at Week 48 in Treatment-Naïve HIV-1-Infected Patients: A Randomized, Multinational, Multicenter Trial
Cooper, David A., Cordery, Damien V., Zajdenverg, Roberto, Ruxrungtham, Kiat, Arastéh, Keikawus, Bergmann, Frank, Neto, José L. de Andrade, Scherer, Joseph, Chaves, Ricardo L., Robinson, Patrick, LandVolume:
11
Language:
english
Journal:
PLOS ONE
DOI:
10.1371/journal.pone.0144917
Date:
January, 2016
File:
PDF, 731 KB
english, 2016